Patents by Inventor Esteban Braggio

Esteban Braggio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and materials for assessing responsiveness to lenalidomide, thalidomide, and/or other thalidomide analogs
    Patent number: 9662319
    Abstract: This document provides methods and materials related to assessing responsiveness to lenalidomide, thalidomide, and/or other IMiDs (structural and functional analogues of thalidomide that represent a promising new class of immunomodulators). For example, methods and materials for using CRBN levels to determine whether or not cancer cells (e.g., multiple myeloma cells) are susceptible to lenalidomide, thalidomide, and/or other IMiDs are provided.
    Type: Grant
    Filed: March 8, 2012
    Date of Patent: May 30, 2017
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Alexander Keith Stewart, Peter Bergsagel, Rafael Fonseca, Esteban Braggio
  • METHODS AND MATERIALS FOR ASSESSING RESPONSIVENESS TO LENALIDOMIDE, THALIDOMIDE, AND/OR OTHER THALIDOMIDE ANALOGS
    Publication number: 20140066480
    Abstract: This document provides methods and materials related to assessing responsiveness to lenalidomide, thalidomide, and/or other IMiDs (structural and functional analogues of thalidomide that represent a promising new class of immunomodulators). For example, methods and materials for using CRBN levels to determine whether or not cancer cells (e.g., multiple myeloma cells) are susceptible to lenalidomide, thalidomide, and/or other IMiDs are provided.
    Type: Application
    Filed: March 8, 2012
    Publication date: March 6, 2014
    Applicant: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventors: Alexander Keith Stewart, Peter Bergsagel, Rafael Fonseca, Esteban Braggio